By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



1971 Old Cuthbert Road

Cherry Hill  New Jersey  08034  U.S.A.
Phone: 856-433-6088 Fax: 856-354-1077



Company News
Nuvilex (NVLX)'s Partner, Austrianova, Receives Prestigious Emerging Enterprises 2014 Best Innovation Award In Singapore 9/8/2014 7:28:11 AM
Nuvilex (NVLX) Submits Application For Orphan Drug Designation To The European Medicines Agency For Its Cell-In-A-Box® Treatment For Pancreatic Cancer 9/2/2014 10:41:03 AM
Nuvilex (NVLX) Begins Preclinical Studies With Translational Drug Development To Determine If Nuvilex's Unique Cancer Treatment Can Slow Accumulation Of Malignant Ascites Fluid 8/20/2014 7:36:40 AM
Nuvilex (NVLX) Announces Publication Of Combined Results Of The Initial Phase 1/2 Clinical Trial And A Second Phase 2 Clinical Trial Of The Cell-In-A-Box® Plus Ifosfamide Combination In Patients With Advanced, Inoperable Pancreatic Cancer 8/14/2014 7:45:24 AM
Nuvilex (NVLX) Provides Update On Status Of Preclinical Studies At Translational Drug Development 8/13/2014 7:29:57 AM
Nuvilex (NVLX) Announces That Dr. Richard M. Hyslop Will Present At The American Chemical Society Annual Meeting On "Sustainable, Green Chemistry And Medicine: Targeted Cannabinoid-Based Chemotherapy Utilizing Cell-In-A-Box® Live Cell Encapsulation Technology 8/4/2014 8:30:14 AM
Nuvilex (NVLX) And Austrianova Announce Results Of Clinical Trial In Dogs With Mammary Tumors Treated With Cell-In-A-Box® Plus Cyclophosphamide 7/17/2014 7:49:57 AM
Nuvilex (NVLX) Provides Shareholder Update On Milestone Accomplishments 7/14/2014 8:03:14 AM
Nuvilex (NVLX) Scheduled To Begin Preclinical Studies In Early August 7/9/2014 10:28:19 AM
Nuvilex (NVLX) Eyeing Partnership For Its Share Of Future $114 Billion Diabetes Market 7/8/2014 11:53:11 AM